You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A computational platform to improve the prioritization of drugs and target genes for therapeutic intervention

    SBC: Genetic Networks, LLC            Topic: 100

    Project Summary This project proposes further development of a computational discovery platform shown to quantifiably identify and prioritize both targets and compounds for therapeutic intervention, which will accelerate the development of newer, more effective drugs with fewer side-effects. This platform is based on a novel fusion of two state of the art computational approaches (phenolog mapping ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  2. A DIGITAL TELEMETRY MONITOR WITH MODULAR FEATURES

    SBC: United States Control            Topic: N/A

    N/A

    SBIR Phase I 1987 Department of Health and Human Services
  3. Advanced CLAD PERG system with minimal patient preparation for clinical settings

    SBC: JORVEC CORP.            Topic: N

    AbstractGlaucoma is one of a number of optic nerve diseases which lead to retinal ganglion cellsRGCdegenerationultimately manifesting in a functional loss of vision if left untreatedThere exist a number of therapeutic approaches to treat these conditionsbut there are currently no clinical methods to detect the onset of RGC dysfunctionThe Pattern ElectroretinogramPERGis the only established tool to ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. AHTP-comet: development of an automated, high throughput comet assay system

    SBC: ENGINEERING RESOURCES GROUP INC            Topic: NIEHS

    PROJECT SUMMARY Genomic instabilityinduced by DNA damageand partly mitigated by DNA repair and antioxidantsplays a critical role in the pathogenesis of many major human diseasessuch as neurodegenerationcancer and cardiovascular diseasetogether with agingThere is a critical need for automated assays that can perform these assessmentsand bring them into greater routine usewhich will help advance our ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. A MICROCOMPUTER-BASED DNA GEL ELECTROPHORESIS IMAGE ANALYSIS

    SBC: Genetics Data Services Inc.            Topic: N/A

    THIS PROJECT IS TO DESIGN AND CONSTRUCT A MICROCOMPUTER-BASED INSTRUMENT FOR QUANTITATING SIZE DISTRIBUTIONS OF NUCLEIC ACIDS (DNA AND RNA) SEPARATED ACCORDING TO SIZE BY GEL ELECTROPHORESIS. THE STARTING POINT FOR ANALYSIS OF FLUORESCENCE-STAINED DNA IN GELS WILL BE THE IMAGE DIGITIZATION OF THE ENTIRE GEL ELECTROPHORETIC PATTERN (OR SPECIFIED PORTIONS OF IT) SO THAT THE RELATIVE INTENSITIES OF F ...

    SBIR Phase I 1987 Department of Energy
  6. Analytics-Based Platform for Diabetic Retinopathy Care Management

    SBC: RETINAL CARE INC            Topic: NEI

    ABSTRACT Despite the overefficacy of diabetic retinopathyDRtreatmentit continues to be the leading cause of blindness in working age AmericansOvermillion adults in the US have diabetesOf thesewill develop DR andwill develop vision threatening DRVTDRCurrentlyless than half of all patients with diabetes receive the recommended annual dilated eye exam andof those diagnosed with VTDRonlyundergo timely ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. An integrated electrical impedance myography platform for neuromuscular disease classification and diagnosis

    SBC: MYOLEX, INC.            Topic: 103

    Project SummaryImproved methods for the bedside diagnosis and evaluation of neuromuscular disorders are needed. One technology that is finding increasing use for this purpose is electrical impedance myography (EIM). In EIM, a very weak, high frequency electrical current is passed through a muscle of interest and the resulting surface voltages are measured. Disease associated alterations in the com ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. A novel PPAR-a agonist for treating retinal inflammation and vascular hyper-permeability

    SBC: EXCITANT THERAPEUTICS LLC            Topic: n

    PROJECT SUMMARY The aim of this proposal is to develop a small molecule suitable for long term systemic administration to prevent treat DRCurrent standard of care for diabetic retinopathyDRor other ocular diseases with an obvious dysfunctional microvasculature basisrely on treatment options that are inherently challenged with technical limitations and financial constraintsFor examplehigh costrequi ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. ANTIGENICITY OF GONOCOCCAL PILUS OLIGOMERS

    SBC: Immunomed Corpon            Topic: N/A

    THE DEVELOPMENT OF A SAFE AND EFFICACIOUS VACCINE FOR GONORRHEA BASED ON OLIGOMERS FROM PILI IS A MAJOR GOAL OF IMMUNOMED CORPORATION. EARLY ATTEMPTS TO DEVELOP GONORRHEA VACCINES USING INTACT PILI FAILED BECAUSE OF ANTIGENIC DIVERSITY AMONG THE BACTERIAL STRAINS IN THE POPULATION. A PRELIMINARY STUDY OF OLIGOMERS FROM THE TYPE 2 COLONIAL FORM OF NEISSERIA GONORRHOEAE HAS SHOWN THAT THEY WERE BETT ...

    SBIR Phase I 1987 Department of Health and Human Services
  10. A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty

    SBC: Longeveron LLC            Topic: NIA

    Aging Frailty is a biologically driven geriatric syndrome of multisystem physiological decline that is distinct from normal aging and disproportionately increases vulnerability to adverse clinical outcomes. Frailty has an overall prevalence of 10% of those 65 years and older, and there is growing awareness in the geriatric community to diagnose and treat this condition, as it is not an inevitable ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government